Practical Aspects of Administration of OnabotulinumtoxinA (Botox®) in the Treatment of OAB

October 9, 2014

Practical Aspects of the Administration of OnabotulinumtoxinA (Botox®) in the Treatment of Overactive Bladder (OAB)

In this presentation, Eric Rovner, MD discusses the clinical and practical aspects of using onabotulinumtoxinA (Botox®), an option for the management of OAB in adult patients who have an inadequate response or who are intolerant to oral medications.  

The benefits of treating OAB symptoms with Botox®, including the reduction in urgency, urinary incontinence and frequency, and the overall improvement in treated patients' quality of life, are presented. Dr. Rovner focuses on communication strategies in counseling patients about the benefits and potential adverse effects of treatment with Botox® in patients. He shares in detail the process of patient care from pre-treatment through the treatment and the patient being discharged from the office.

He provides practical tips in using Botox® in your office practice or in the clinic setting. In just over 15 minutes, you have the opportunity to participate in Dr. Rovner's considerations for treatment of OAB with Botox®.

Eric S. Rovner, MD
Professor of Urology - Medical University of South Carolina

Click to read the abstract


Eric S. Rovner, M.D. is a Professor in the Department of Urology at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. He is the director of the Section of Voiding Dysfunction, Female Urology and Urodynamics in the Department of Urology at MUSC. He is currently a member of the Executive Committee of SUFU serving as the President. He is a Board Certified member of the American Urological Association, Fellow of the American College of Surgeons, Society of Pelvic Surgeons, and the Society of University Urologists. Dr. Rovner has served on several committees for the WHO International Consultation on Incontinence and is currently a member of the AUA Urodynamics Guidelines Committee. He served as a member of the AUA/ABU Examination Committee and the AUA SUI Guidelines Committee.

Dr. Rovner’s research interests include the study of voiding dysfunction, overactive bladder, interstitial cystitis, neurourology and urodynamics. He has a highly specialized clinical practice within Urology and sees mostly patients with complex voiding problems including urinary incontinence, vaginal prolapse, urinary fistulae and neurogenic bladder dysfunction. He has held several visiting professorships and is the author or coauthor of over 100 peer-reviewed scientific articles, over 25 book chapters, dozens of monographs, as well as a lay book on urinary incontinence.